GUO Qingchun, ZHANG Jiegen, GAO Yaqian, LYU Yongsheng, ZHOU Pengfei, LI Qinzhao. Expressions of miR-21 and programmed cell death factor 4 in alveolar macrophages of bronchoalveolar lavage fluid in patients with chronic obstructive pulmonary disease[J]. Journal of Clinical Medicine in Practice, 2022, 26(5): 117-121. DOI: 10.7619/jcmp.20212508
Citation: GUO Qingchun, ZHANG Jiegen, GAO Yaqian, LYU Yongsheng, ZHOU Pengfei, LI Qinzhao. Expressions of miR-21 and programmed cell death factor 4 in alveolar macrophages of bronchoalveolar lavage fluid in patients with chronic obstructive pulmonary disease[J]. Journal of Clinical Medicine in Practice, 2022, 26(5): 117-121. DOI: 10.7619/jcmp.20212508

Expressions of miR-21 and programmed cell death factor 4 in alveolar macrophages of bronchoalveolar lavage fluid in patients with chronic obstructive pulmonary disease

More Information
  • Received Date: June 16, 2021
  • Available Online: March 28, 2022
  • Published Date: March 14, 2022
  •   Objective  To investigate the expression levels of miR-21 and programmed cell death factor 4 (PDCD4) in alveolar macrophages (AM) of bronchoalveolar lavage fluid (BALF) in patients with chronic obstructive pulmonary disease (COPD).
      Methods  A total of 135 COPD patients were selected as study objects (COPD group). According to the patients' conditions, they were divided into stable COPD group (62 cases) and acute exacerbation stage of COPD (AECOPD) group (73 cases); a total of 73 healthy people who underwent bronchoscopy due to laryngeal foreign body sensation were selected for control study (normal group). The general data of COPD group and normal group were compared; real-time quantitative polymerase chain reaction (qRT-PCR) was used to detect the relative expression of miR-21 and PDCD4 mRNA in BALF AM; Pearson method was used to analyze the correlations between the expression of miR-21 and PDCD4 mRNA in BALF AM and lung function indexes, and the correlation between miR-21 expression level and PDCD4 mRNA expression level; receiver operating characteristic (ROC) curve was used to evaluate the diagnostic value of miR-21 and PDCD4 mRNA in BALF AM for COPD.
      Results  Compared with the normal group, the percentage of forced expiratory volume in the first second (FEV1) in expected value (FEV1%) and FEV1/forced vital capacity (FVC) level in the COPD group were significantly decreased (P < 0.05); compared with the normal group, the expression levels of miR-21 in BALF AM were significantly higher, and the expression levels of PDCD4 mRNA were significantly lower of patients in the stable COPD group and AECOPD group (P < 0.05); compared with the stable COPD group, the expression level of miR-21 in BALF AM of the AECOPD group was significantly higher, and the expression level of PDCD4 mRNA was significantly lower (P < 0.05); the expression levels of miR-211 in BALF AM of COPD patients were negatively correlated with PDCD4 mRNA level, FEV1% and FEV1/FVC (P < 0.05), while PDCD4 mRNA expression was positively correlated with FEV1% and FEV1/FVC (P < 0.05); the area under the curve (AUC) of miR-21 and PDCD4 mRNA in BALF AM were 0.844 and 0.849, corresponding cut-off value were 1.54 and 0.70, sensitivity were 70.4% and 77.8%, specificity were 86.3% and 80.8%, respectively; the AUC of the combined diagnosis of COPD was 0.903, and its sensitivity and specificity were 90.4% and 84.9%, respectively.
      Conclusion  The expression of miR-21 in BALF AM of COPD patients is increased, and the expression of PDCD4 is decreased. MiR-21 may interact with PDCD4, and then synergistically affect the pathological process of COPD. Both levels are helpful for clinical screening of COPD patients and evaluation of patients' condition.
  • [1]
    ABUKHALAF J, DAVIDSON R, VILLALOBOS N, et al. Chronic obstructive pulmonary disease mortality, a competing risk analysis[J]. Clin Respir J, 2018, 12(11): 2598-2605. doi: 10.1111/crj.12963
    [2]
    MANNINO D M. Biomarkers for chronic obstructive pulmonary disease diagnosis and progression: insights, disappointments and promise[J]. Curr Opin Pulm Med, 2019, 25(2): 144-149. doi: 10.1097/MCP.0000000000000549
    [3]
    HUA L, XIA H, XU W B, et al. Prediction of microRNA and gene target from an integrated network in chronic obstructive pulmonary disease based on canonical correlation analysis[J]. Technol Health Care, 2018, 26(S1): 121-134.
    [4]
    HUANG X W, ZHU Z X, GUO X R, et al. The roles of microRNAs in the pathogenesis of chronic obstructive pulmonary disease[J]. Int Immunopharmacol, 2019, 67: 335-347. doi: 10.1016/j.intimp.2018.12.013
    [5]
    ZENG Z P, HE S Y, LU J J, et al. microRNA-21 aggravates chronic obstructive pulmonary disease by promoting autophagy[J]. Exp Lung Res, 2018, 44(2): 89-97. doi: 10.1080/01902148.2018.1439548
    [6]
    韩昕, 白维君. 非小细胞肺癌组织miR-155、PDCD4表达变化及意义[J]. 山东医药, 2019, 59(25): 61-64. https://www.cnki.com.cn/Article/CJFDTOTAL-SDYY201925019.htm
    [7]
    中华医学会呼吸病学分会慢性阻塞性肺疾病学组. 慢性阻塞性肺疾病诊治指南(2007年修订版)[J]. 中华结核和呼吸杂志, 2007, 30(1): 8-17. doi: 10.3760/j:issn:1001-0939.2007.01.004
    [8]
    CELLI B R, WEDZICHA J A. Update on clinical aspects of chronic obstructive pulmonary disease[J]. N Engl J Med, 2019, 381(13): 1257-1266. doi: 10.1056/NEJMra1900500
    [9]
    YANG X, ZHANG Q H, ZHANG M, et al. Serum microRNA signature is capable of early diagnosis for non-small cell lung cancer[J]. Int J Biol Sci, 2019, 15(8): 1712-1722. doi: 10.7150/ijbs.33986
    [10]
    李卫东, 张东明, 周可幸, 等. 急性呼吸窘迫综合征中miRNAs的生物标记作用与调控机制[J]. 生命的化学, 2019, 39(1): 153-158. https://www.cnki.com.cn/Article/CJFDTOTAL-SMHX201901023.htm
    [11]
    MANEECHOTESUWAN K. Role of microRNA in severe asthma[J]. Respir Investig, 2019, 57(1): 9-19. doi: 10.1016/j.resinv.2018.10.005
    [12]
    TANG K, ZHAO J P, XIE J G, et al. Decreased miR-29b expression is associated with airway inflammation in chronic obstructive pulmonary disease[J]. Am J Physiol Lung Cell Mol Physiol, 2019, 316(4): L621-L629. doi: 10.1152/ajplung.00436.2018
    [13]
    HE S Y, LI L Q, SUN S H, et al. A novel murine chronic obstructive pulmonary disease model and the pathogenic role of microRNA-21[J]. Front Physiol, 2018, 9: 503. doi: 10.3389/fphys.2018.00503
    [14]
    赵晓琴, 邢莎莎. 血清微RNA-21在慢性阻塞性肺疾病患者中的诊断价值[J]. 中国药物与临床, 2018, 18(6): 1011-1012. https://www.cnki.com.cn/Article/CJFDTOTAL-YWLC201806076.htm
    [15]
    HWANG S K, JEONG Y J, CHANG Y C. PDCD4 inhibits lung tumorigenesis by the suppressing p62-Nrf2 signaling pathway and upregulating Keap1 expression[J]. Am J Cancer Res, 2020, 10(2): 424-439.
    [16]
    ZHONG B, YANG X D, SUN Q Z, et al. PDCD4 modulates markers of macrophage alternative activation and airway remodeling in antigen-induced pulmonary inflammation[J]. J Leukoc Biol, 2014, 96(6): 1065-1075. doi: 10.1189/jlb.3A0313-136RRR
    [17]
    MATEU-JIMENEZ M, CURULL V, RODRÍGUEZ-FUSTER A, et al. Profile of epigenetic mechanisms in lung tumors of patients with underlying chronic respiratory conditions[J]. Clin Epigenetics, 2018, 10: 7. doi: 10.1186/s13148-017-0437-0
    [18]
    张占强, 吴春艳, 方彬, 等. Th17/Treg、IL-17在慢性阻塞性肺疾病患者中的表达及与肺功能的相关性[J]. 现代中西医结合杂志, 2018, 27(22): 2419-2423, 2494. doi: 10.3969/j.issn.1008-8849.2018.22.007
  • Cited by

    Periodical cited type(6)

    1. 韩秀燕,许华,张沁丽. 血清尿酸水平与脑血管病因果关系的双向两样本孟德尔随机化研究. 实用临床医药杂志. 2025(01): 66-72 . 本站查看
    2. 罗丽,刘锋伟,马丹丹,张玮. 靳三针联合感觉统合训练治疗儿童语言障碍对语言功能及适应行为的影响. 实用中医药杂志. 2024(04): 749-751 .
    3. 刘洁洁,唐纯志. 靳三针疗法治疗痴呆Meta分析. 中国中医药图书情报杂志. 2024(04): 171-177 .
    4. 唐青青,李铁,李霞,杨宁,张世苹,张凯强,萨仁. 萨仁“南海调神”针法经验浅析. 中国针灸. 2024(10): 1177-1180 .
    5. 刘红喜,路梦颖,梁晓,魏竞竞,刘悦,陈云梦,迟显苏,付国静,张允岭. 基于髓海理论运用填精益髓法辨治中医脑病. 中医杂志. 2023(18): 1877-1884 .
    6. 杜明明,刘仕杰,宋金萍,谷慧敏. 补髓通窍益脑汤联合靳三针对血管性痴呆患者的影响. 光明中医. 2023(18): 3564-3566 .

    Other cited types(2)

Catalog

    Article views (258) PDF downloads (17) Cited by(8)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return